Kovina Therapeutics
PrivateLast Round
Grant
Nov 2, 2022
Total Funding Raised
$4.98M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kovina Therapeutics operates in Healthcare & Life Sciences and is based in Indianapolis, Indiana. Its latest recorded funding round was a Grant round in November 2022.
Kovina Therapeutics is a biotechnology company developing first-in-class small molecule antiviral therapies to treat cancers and pre-malignant infections caused by Human Papillomavirus (HPV).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kovina Therapeutics Comparables
Compare Kovina Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Toragen, Inc. | 84% | |
| Antiva Biosciences | 77% | |
| Loma Therapeutics | 77% |
For institutional investors. Book with your work email.
Kovina Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 2, 2022 | ||||
| Grant | Sep 13, 2022 | ||||
| Grant | Jun 18, 2022 | ||||
| Seed | Oct 20, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kovina Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| Elevate Ventures | Seed |
| BioCrossroads | Seed |
| IU Ventures | Seed |
| National Institute of Dental and Craniofacial Research | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 40% MoM.
- Nov 12, 2025
Monthly visitors grew 597% MoM, from 237 to 1.7K.
For institutional investors. Book with your work email.
Kovina Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kovina Therapeutics's valuation, stock price, and market status.
Is Kovina Therapeutics a public or private company?
Kovina Therapeutics is a private company.
What is the current stock price of Kovina Therapeutics?
Kovina Therapeutics is a private company, so its shares have no public market price. Caplight tracks Kovina Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kovina Therapeutics worth (valuation)?
Valuation information for Kovina Therapeutics is not publicly available.
Can I buy Kovina Therapeutics stock?
Kovina Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kovina Therapeutics's last funding round?
Kovina Therapeutics's most recent funding round was Grant on November 2, 2022.
Who are the main investors in Kovina Therapeutics?
Key investors in Kovina Therapeutics include Elevate Ventures.
Will Kovina Therapeutics IPO soon?
No public IPO plans have been announced for Kovina Therapeutics.
How can I track Kovina Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kovina Therapeutics's shares on secondary markets.